Jornada Ideas y Realidades sobre Salud y Migración

Simposio: Ideas y Realidades sobre Salud y Migración (Europubhealth+). Una perspectiva desde España   Escuela Andaluza de Salud Pública Granada, 27 de abril de 2026. 15:30h-18:30h   Este evento ha sido organizado por el alumnado del XX Máster de Excelencia en Salud Pública (Europubhealth+), con el apoyo de EASP. PROGRAMAWEB RED ISIRWEB DEL EUROPUBHEALTHPLAYLIST DE…

Jornada Parkinson

Conectando VidasJornada para pacientes de Parkinson y otros parkinsonismos y personas cuidadoras Escuela Andaluza de Salud Pública. 14 de abril de 2026 Secretaría de Jornadas. jornadas.easp@juntadeandalucia.es  Dirigida a: Personas con Parkinson y otros parkinsonismos, y personas cuidadoras, formales como informales. Profesionales sanitarios implicados en la atención de estos pacientes, medicina de atención primaria, neurología, especialistas…

Conferencias Ciclo esalud

La Directora Gerente de la Escuela Andaluza de Salud Pública y la Dirección del XLI Máster de Formación Permanente en Salud Pública y Gestión Sanitaria y XX Máster Europeo en Excelencia en Salud Pública – Europubhealth+, tienen el honor de invitarte a asistir al CICLO DE CONFERENCIAS: DESAFÍOS EN GESTIÓN SANITARIA EN LA ESFERA INTERNACIONAL…

Intake of the Total, Classes, and Subclasses of (Poly)phenols and Breast Cancer Risk: A Prospective Analysis of the EPIC Study

Polyphenols represent the largest and most diverse class of dietary antioxidants. Epidemiological evidence linking specific (poly)phenol classes, such as flavonoids and lignans, to breast cancer (BC) risk remains limited and largely inconclusive in prospective studies. The aim of this study is to examine the association between the intake of total (poly)phenols—and its classes and subclasses—and…

Associations between dietary exposure to dioxins and polychlorinated biphenyls (PCBs) and Longitudinal changes in weight and waist circumference– an EPIC study

Background: Obesity is a growing global health concern. Some evidence suggests that exposure to polychlorinated biphenyls (PCBs) and dioxins, may play a role in weight gain, but human prospective data are limited and have shown inconsistent results. Therefore, this study investigate the association between dietary exposure to dioxins and PCBs and changes in weight and…

Nuevas formas de reticencia a la vacunación en la era pos-COVID-19: un estudio cualitativo

Objetivo Analizar los argumentos para dudar o rechazar cualquiera de las vacunas contra la COVID-19 y cómo estos discursos han podido modificarse tras la experiencia de la pandemia. Método Se desarrolló un estudio cualitativo exploratorio-descriptivo durante 2021-2022, con cuatro entrevistas semiestructuradas y tres grupos focales mediante muestreo teórico a personas reticentes a las vacunas contra…

Higher intake of dietary dicarbonyl compounds is associated with lower incidence of type 2 diabetes: European Prospective Investigation into Cancer and Nutrition (EPIC)-InterAct case-cohort study

Purpose Dicarbonyls are reactive precursors of advanced glycation end-products. They are formed during food processing, and endogenously in humans during glycolysis and lipid peroxidation. Higher plasma dicarbonyls, particularly methylglyoxal (MGO), promote insulin resistance and type 2 diabetes, but the association between dietary dicarbonyls intake and type 2 diabetes is unknown. This study examined the associations…

Proteomics signature of moderate-to-vigorous physical activity and risk of multimorbidity of cancer and cardiometabolic diseases

Background Moderate-to-vigorous physical activity (MVPA) is inversely associated with risks of cancer, cardiovascular diseases (CVD), type 2 diabetes (T2D), and their co-occurrence, defined as multimorbidity; however, the underlying biological pathways remain unclear. Methods In 33,806 UK Biobank participants with 2911 measured blood proteins, a proteomic signature of MVPA was derived with linear and LASSO regressions.…

The complex price setting and reimbursement of non-industrial advanced therapy medicinal products

Background Advanced Therapy Medicinal Products (ATMPs) developed under the Hospital Exemption (HE) offer innovative treatments for patients with unmet medical needs, but their pricing and reimbursement (P&R) remain fragmented and poorly understood. This paper examines the P&R landscape for HE-ATMPs developed by academic developers in Spain, based on the Spanish costing guideline and extends the…